312 related articles for article (PubMed ID: 9309087)
1. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
McCaffrey JA; Herr HW
Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
3. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for bladder cancer.
Sonpavde G; Lerner SP
Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.
Smith MR; Kantoff PW
Semin Oncol; 1995 Dec; 22(6):625-32. PubMed ID: 8539637
[TBL] [Abstract][Full Text] [Related]
6. Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results.
Scher HI
Urol Clin North Am; 1992 Nov; 19(4):747-59. PubMed ID: 1441029
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
Stöckle M
Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
[TBL] [Abstract][Full Text] [Related]
10. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
Izawa JI; Chin JL; Winquist E
Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
[TBL] [Abstract][Full Text] [Related]
11. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
Aparicio AM; Elkhouiery AB; Quinn DI
Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
13. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
Suttmann H; Kamradt J; Lehmann J; Stöckle M
BJU Int; 2007 Dec; 100(6):1225-8. PubMed ID: 17979921
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
[TBL] [Abstract][Full Text] [Related]
16. The role of chemotherapy in the management of the patient with T3b bladder cancer.
Millikan R; Dinney CP
Semin Urol Oncol; 1996 May; 14(2):81-5. PubMed ID: 8734735
[TBL] [Abstract][Full Text] [Related]
17. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
20. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
